Former hedge fund manager purchases AIDS drug, raises price from $13.50 to $750 per tablet
According to the New York Times, a former hedge fund manager turned pharmaceutical entrepreneur has…
According to the New York Times, a former hedge fund manager turned pharmaceutical entrepreneur has…